Recombinant Chromobacterium violaceum UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
lpxC; CV_4337UDP-3-O-acyl-N-acetylglucosamine deacetylase; UDP-3-O-acyl-GlcNAc deacetylase; EC 3.5.1.108; UDP-3-O-[R-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-304
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chromobacterium violaceum (strain ATCC 12472 / DSM 30191 / JCM 1249 / NBRC 12614 / NCIMB 9131 / NCTC 9757)
Target Names
lpxC
Target Protein Sequence
MILQRTLKQA ISATGVGLHS GERVKLTLLP APPDTGIVFR RTDLPEPVDV KVEPSLVNDT RLSSTLVTDT GVRVGTIEHL MSAFAGFGID NLVVEVTAAE IPIMDGSAAP FLYLLQTAGV VDQPKKKRFI RVKQSVMVED RGVWVRLDPH DGFKITLSIE FNHPAFNRAP QTVEVDFARH SYMDEISRAR TFGFMHEVEY MRNHGLGRGG SLDNAIVIDD EYVLNPEGLR FPDEFVRHKI LDAIGDLYIV GHPLIAAFSG HKSGHAMNNR LLRKLLETPE AWEFASFDDP LDAPSSFHQL PPQE
Uniprot No.

Target Background

Function
Function: Catalyzes the hydrolysis of UDP-3-O-myristoyl-N-acetylglucosamine to UDP-3-O-myristoylglucosamine and acetate; this is the committed step in lipid A biosynthesis.
Database Links

KEGG: cvi:CV_4337

STRING: 243365.CV_4337

Protein Families
LpxC family

Q&A

What is the biological function of UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC) in Chromobacterium violaceum?

LpxC is a critical zinc-dependent metalloenzyme that catalyzes the second step in lipid A biosynthesis, which involves the deacetylation of UDP-3-O-(3-hydroxymyristoyl)-N-acetylglucosamine. In Chromobacterium violaceum, as in other Gram-negative bacteria, this enzyme plays an essential role in the biosynthesis of lipopolysaccharide (LPS), a major component of the outer membrane. The enzyme's activity directly influences bacterial membrane integrity, antibiotic resistance, and virulence potential. When studying C. violaceum LpxC, researchers should note that this organism has unique regulatory mechanisms that may affect LpxC expression, such as the antibiotic-induced response (air) system that regulates various cellular processes in response to environmental stressors .

How does C. violaceum LpxC structure compare to LpxC from other Gram-negative bacteria?

While the crystal structure of C. violaceum LpxC has not been fully characterized in the provided search results, structural analysis would typically reveal a conserved catalytic domain with some species-specific variations. Based on structural studies of related proteins from C. violaceum, such as the omega transaminase , we can anticipate that the LpxC would maintain the canonical α/β fold with a catalytic zinc ion coordinated by conserved residues.

Methodologically, researchers should approach structural comparisons using:

  • Multiple sequence alignment of C. violaceum LpxC with well-characterized LpxC enzymes from E. coli, P. aeruginosa, and other Gram-negative bacteria

  • Homology modeling based on existing crystal structures

  • Circular dichroism spectroscopy to compare secondary structure elements

  • Thermal shift assays to assess structural stability differences

These approaches would highlight both conserved catalytic regions and potential species-specific variations that might influence inhibitor binding or substrate specificity.

What expression systems are most effective for producing recombinant C. violaceum LpxC?

When expressing recombinant C. violaceum LpxC, researchers should consider several methodological approaches based on the characteristics of this enzyme:

Expression System Comparison Table:

Expression SystemAdvantagesConsiderationsRecommended Conditions
E. coli BL21(DE3)High yield, simple protocolPotential inclusion body formationInduction: 0.5mM IPTG at OD600 0.6-0.8; 18°C overnight
E. coli Rosetta™Enhanced rare codon translationSlightly lower yieldsInduction: 0.2mM IPTG; 25°C for 6 hours
C. violaceum nativeNative folding environmentComplex cultivation requirementsConsider the air system regulation
Cell-free systemAvoids toxicity issuesHigher cost, lower yieldSupplement with zinc for proper folding

To maximize soluble protein yield, consider these methodological refinements:

  • Co-express with chaperone proteins (GroEL/GroES)

  • Add 0.1mM ZnSO4 to the growth medium to ensure proper zinc incorporation

  • Include 5% glycerol in purification buffers to enhance stability

  • Express as a fusion protein with solubility tags (SUMO, MBP, or TRX)

Drawing from approaches used with other C. violaceum enzymes, expression conditions should be optimized while considering the regulatory mechanisms that may affect protein production in this organism .

What are the optimal conditions for assaying C. violaceum LpxC enzymatic activity?

For robust and reproducible assessment of C. violaceum LpxC activity, researchers should implement the following methodological approach:

Standard Assay Protocol:

  • Buffer composition: 50mM HEPES (pH 7.5), 0.01% Triton X-100, 100mM NaCl, and 10μM ZnSO4

  • Temperature: 30°C (reflective of C. violaceum's environmental niche)

  • Substrate concentration: 25-50μM UDP-3-O-[3-hydroxymyristoyl]-N-acetylglucosamine

  • Enzyme concentration: 5-20nM purified recombinant LpxC

Activity Detection Methods:

  • HPLC analysis of reaction products

  • Coupled enzymatic assay measuring acetate release

  • Fluorescence-based assay using modified substrates

  • LC-MS/MS for precise product quantification

When designing assays, consider that the enzyme's activity may be influenced by environmental factors that affect C. violaceum, such as temperature shifts and antibiotic presence, which have been shown to trigger regulatory responses in this organism . Additionally, include proper controls for zinc dependency by testing activity in the presence of EDTA and subsequent reactivation with zinc supplementation.

How do environmental stressors affect LpxC expression and activity in C. violaceum?

C. violaceum employs sophisticated regulatory mechanisms to respond to environmental stressors, which likely extend to LpxC regulation. Research methodologies to investigate this relationship should include:

  • Transcriptomic Analysis: RNA-seq comparing LpxC expression under various stress conditions (antibiotic exposure, temperature shifts, nutrient limitation) to identify regulatory patterns. The antibiotic-induced response (air) system identified in C. violaceum responds to translation-inhibiting antibiotics and could potentially influence LpxC expression .

  • Proteomics Approach: Quantitative proteomics to measure LpxC protein levels in response to stressors, coupled with post-translational modification analysis.

  • Reporter Systems: Construction of transcriptional fusions between the LpxC promoter and reporter genes (GFP, luciferase) to monitor expression in real-time.

  • Two-Component System Analysis: Investigation of potential regulation by two-component systems like the air system (AirS/AirR) that has been shown to regulate violacein production and virulence in C. violaceum .

The connection between stress response and LpxC activity is particularly relevant given C. violaceum's environmental adaptability and occasional pathogenicity. Researchers should design experiments that capture both acute and chronic stress responses, as these may differentially affect LpxC regulation.

What is the potential interaction between the air regulatory system and LpxC expression in C. violaceum?

The antibiotic-induced response (air) system in C. violaceum, comprising AirS (sensor histidine kinase), AirR (response regulator), and AirM (oxidoreductase with molybdopterin-binding domain), represents an intriguing regulatory mechanism that responds to translation-inhibiting antibiotics . Though direct regulation of LpxC by this system has not been established in the provided research, methodological approaches to investigate this potential relationship include:

  • Comparative Transcriptomics: RNA-seq analysis comparing wild-type and air system mutants (ΔairS, ΔairR, ΔairM) to identify differentially expressed genes, including LpxC.

  • Chromatin Immunoprecipitation (ChIP-seq): Using tagged AirR protein to identify DNA binding sites, potentially revealing direct regulation of LpxC transcription.

  • Electrophoretic Mobility Shift Assays (EMSA): Testing direct binding of purified AirR to the LpxC promoter region.

  • Phenotypic Analysis: Comparing LPS structure and antibiotic susceptibility between wild-type and air system mutants to identify functional consequences of potential regulation.

This investigation would contribute to understanding how C. violaceum coordinates membrane biogenesis (via LpxC) with stress responses, particularly in response to antibiotics targeting translation .

What methodologies are recommended for determining inhibitor binding sites in C. violaceum LpxC?

To characterize inhibitor binding sites in C. violaceum LpxC, researchers should employ a multi-faceted structural biology approach:

  • X-ray Crystallography: Following purification protocols similar to those used for other C. violaceum enzymes , crystallize LpxC in complex with various inhibitors. Data collection at resolutions better than 2.0Å will allow precise mapping of binding interactions.

  • Nuclear Magnetic Resonance (NMR) Spectroscopy: For dynamic binding analysis, especially with labeled inhibitors to track binding modes in solution.

  • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): To map conformational changes upon inhibitor binding, revealing allosteric effects.

  • Molecular Docking and Molecular Dynamics Simulations: Computational approaches to predict binding modes and conformational changes, particularly valuable when crystallographic data is challenging to obtain.

  • Site-Directed Mutagenesis: Systematic mutation of predicted binding site residues coupled with activity assays to validate computational and structural findings.

Understanding the binding characteristics specific to C. violaceum LpxC could reveal species-specific inhibitor interactions that might differ from those observed in other Gram-negative bacteria, potentially informing selective inhibitor design.

How can researchers address the challenges in obtaining sufficient quantities of the natural substrate for C. violaceum LpxC enzymatic studies?

The natural substrate for LpxC, UDP-3-O-[3-hydroxymyristoyl]-N-acetylglucosamine, presents challenges for researchers due to its complex structure and limited commercial availability. Methodological solutions include:

  • Enzymatic Synthesis Pathway:

    • Express and purify LpxA from C. violaceum or E. coli

    • React UDP-GlcNAc with acyl-ACP in the presence of LpxA

    • Purify the product using anion exchange chromatography

  • Chemical Synthesis Approach:

    • Synthesize the acyl chain separately

    • Couple to UDP-GlcNAc using protected intermediates

    • Remove protecting groups under mild conditions

  • Substrate Analogs Development:

    • Design and synthesize fluorescent or chromogenic analogs

    • Validate analogs through comparative kinetic analysis

    • Develop high-throughput compatible substrates

  • Alternate Assay Strategies:

    • Product detection assays measuring free acetate

    • Coupled enzyme systems that amplify signal

    • Direct binding assays using thermophoresis or surface plasmon resonance

When working with the synthesized substrate, researchers should verify its authenticity using analytical techniques such as NMR, mass spectrometry, and HPLC comparison with standards. Additionally, substrate stability should be carefully monitored, particularly in assay conditions where degradation might occur.

How does inhibition of C. violaceum LpxC compare to LpxC inhibition in other pathogenic Gram-negative bacteria?

While C. violaceum is generally environmental, its LpxC inhibition studies provide valuable comparative data for antimicrobial development. A methodological approach to this comparative analysis should include:

  • Enzymatic Inhibition Profiles:

    • Determine IC50 values for a panel of LpxC inhibitors against purified enzymes from C. violaceum and other Gram-negative pathogens

    • Analyze enzyme kinetics to distinguish competitive, non-competitive, or uncompetitive inhibition mechanisms

    • Generate the following comparative data table:

Inhibitor ClassC. violaceum LpxC IC50 (μM)E. coli LpxC IC50 (μM)P. aeruginosa LpxC IC50 (μM)Inhibition Mechanism
Hydroxamates[Data needed][Data needed][Data needed]Competitive
Biphenyl derivatives[Data needed][Data needed][Data needed]Mixed
Natural products[Data needed][Data needed][Data needed]Varies
  • Structural Basis Analysis:

    • Perform molecular dynamics simulations comparing inhibitor binding across species

    • Use protein crystallography to identify subtle binding pocket differences

    • Map resistance mutations to understand species-specific inhibitor interactions

  • Whole-Cell Activity Correlation:

    • Compare enzyme inhibition to whole-cell antimicrobial activity

    • Analyze membrane permeability differences that might affect inhibitor access

    • Evaluate efflux contributions to inhibitor efficacy differences

This comparative approach may reveal unique features of C. violaceum LpxC that could inform the development of narrow-spectrum or broad-spectrum LpxC inhibitors with optimized properties.

What research approaches can elucidate the role of LpxC in C. violaceum antibiotic resistance mechanisms?

Understanding LpxC's role in C. violaceum antibiotic resistance requires a multidisciplinary approach:

  • Genetic Manipulation Studies:

    • Create conditional LpxC mutants with tunable expression levels

    • Generate point mutations in the catalytic site to modulate activity without eliminating function

    • Integrate these mutations with the known antibiotic response systems in C. violaceum, particularly the air system

  • Lipidomic Analysis:

    • Compare lipid A structures between wild-type and LpxC-modulated strains

    • Analyze membrane changes in response to antibiotic pressure

    • Correlate lipid A modifications with specific resistance phenotypes

  • Transcriptomic and Proteomic Integration:

    • Perform RNA-seq under LpxC inhibition conditions

    • Identify compensatory pathways activated during LpxC stress

    • Map connections to known resistance mechanisms and the air regulatory system

  • Membrane Integrity Studies:

    • Measure permeability changes using fluorescent probes

    • Quantify outer membrane vesicle formation

    • Assess changes in surface charge and hydrophobicity

The research should specifically investigate how LpxC activity relates to the unique regulatory responses observed in C. violaceum, such as the antibiotic-induced response system that controls various phenotypes including biofilm formation and virulence .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.